First EVER Phase III Clinical Trial for FSGS Announced!

First EVER Phase III Clinical Trial for FSGS Announced TODAY!

Retrophin has announced that their Phase III trial for Sparsentan has launched today. This trial is critical for getting new and better treatments to FSGS patients.

To learn more about clinical trials, contact Chelsey Fix at cfix@nephcure.org.

Leave a Reply